Comparative evaluation of metagenomic and targeted next-generation sequencing for pathogen detection in bronchoalveolar lavage fluid from patients with lower respiratory tract infections: a retrospective cohort study.
- 1Department of Respiratory and Critical Care Medicine, Chifeng Municipal Hospital, Chifeng, Inner Mongolia, China.
- 2Affiliated Chifeng Clinical Medical College of Inner Mongolia Medical University, Chifeng, Inner Mongolia, China.
- 3Department of Endocrinology, Chifeng Municipal Hospital, Chifeng, Inner Mongolia, China.
Abstract
Rapid and precise pathogen identification is crucial for managing lower respiratory tract infections (LRTIs). While metagenomic next-generation sequencing (mNGS) and targeted next-generation sequencing (tNGS) are emerging as valuable diagnostic tools, large-scale studies directly evaluating their real-world impact on antimicrobial stewardship remain scarce. We conducted a retrospective cohort study encompassing 941 patients with suspected LRTIs who underwent bronchoalveolar lavage fluid (BALF) sequencing. Patients were evaluated in either an mNGS cohort (n = 479; DNA-only sequencing) or a tNGS cohort (n = 462; DNA and RNA sequencing). Diagnostic performance, pathogen spectrum, and clinical utility were compared against a composite final clinical diagnosis, which served as the reference standard. Both sequencing platforms demonstrated diagnostic efficacy superior to traditional laboratory tests. In the tNGS cohort, polymicrobial infections were highly prevalent (93.5%). Furthermore, tNGS demonstrated high sensitivity for fastidious pathogens, identifying 54 cases of Mycobacterium tuberculosis (a cohort in which routine smears missed 77.8% of cases) and effectively detecting Pneumocystis jirovecii. The overall diagnostic sensitivity was 90.6% (95% CI: 87.5-93.1%) for mNGS and 73.4% (95% CI:69.2%-77.3%) for tNGS. Guided by tNGS results, clinicians escalated antimicrobial therapy in 22.6% of positive cases. The clinical improvement rate following this targeted escalation was 66.2%, comparable to the 66.7% improvement rate observed in patients receiving appropriate initial empirical therapy (P = 0.946). Both tNGS and mNGS offer substantial diagnostic value for LRTIs, with tNGS showing particular utility in identifying fastidious and low-titer pathogens. Sequencing-guided diagnostics frequently informed antimicrobial adjustments and were associated with favorable clinical progress; however, future prospective paired-testing studies are required to isolate the direct impact of sequencing on patient survival outcomes.
Related
- Metagenomic next-generation sequencing of bronchoalveolar lavage fluid unravels brucellosis in a patient with chronic lung disease and venous thrombosis: A case report.
- Viral metagenomic characterization of HAdV-B-related signals in bronchoalveolar lavage fluid from pediatric and adult clinical cohorts
- Bronchoalveolar Lavage Metagenomic Sequencing in the Early Post-Lung Transplantation Period: A Pilot Comparison with Microbiologic Culture
- Molecular detection of Acanthamoeba genotypes and Pneumocystis jirovecii in bronchoalveolar lavage specimens from immunocompetent patients with respiratory disorders
- Tropheryma whipplei as the Dominant Organism in Bronchoalveolar-Lavage Metagenomic Next-Generation Sequencing: A Single-Centre Case Series of 28 Patients.
BibTeX
@article{zhao2026comparative,
title = {{Comparative evaluation of metagenomic and targeted next-generation sequencing for pathogen detection in bronchoalveolar lavage fluid from patients with lower respiratory tract infections: a retrospective cohort study.}},
author = {Rui Zhao and Heya Na and Wei Miao and Lei Liu and Jing Zhang and Yongshuai Miao and Ying Zhao and Xiaohua Li},
journal = {Frontiers in cellular and infection microbiology},
year = {2026},
month = oct,
doi = {10.3389/fcimb.2026.1877320},
url = {https://europepmc.org/article/MED/42952990},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparative evaluation of metagenomic and targeted next-generation sequencing for pathogen detection in bronchoalveolar lavage fluid from patients with lower respiratory tract infections: a retrospective cohort study.
AU - Rui Zhao
AU - Heya Na
AU - Wei Miao
AU - Lei Liu
AU - Jing Zhang
AU - Yongshuai Miao
AU - Ying Zhao
AU - Xiaohua Li
PY - 2026
DA - 2026/10/14
JO - Frontiers in cellular and infection microbiology
DO - 10.3389/fcimb.2026.1877320
UR - https://europepmc.org/article/MED/42952990
AB - Rapid and precise pathogen identification is crucial for managing lower respiratory tract infections (LRTIs). While metagenomic next-generation sequencing (mNGS) and targeted next-generation sequencing (tNGS) are emerging as valuable diagnostic tools, large-scale studies directly evaluating their real-world impact on antimicrobial stewardship remain scarce. We conducted a retrospective cohort study encompassing 941 patients with suspected LRTIs who underwent bronchoalveolar lavage fluid (BALF) sequencing. Patients were evaluated in either an mNGS cohort (n = 479; DNA-only sequencing) or a tNGS cohort (n = 462; DNA and RNA sequencing). Diagnostic performance, pathogen spectrum, and clinical utility were compared against a composite final clinical diagnosis, which served as the reference standard. Both sequencing platforms demonstrated diagnostic efficacy superior to traditional laboratory tests. In the tNGS cohort, polymicrobial infections were highly prevalent (93.5%). Furthermore, tNGS demonstrated high sensitivity for fastidious pathogens, identifying 54 cases of Mycobacterium tuberculosis (a cohort in which routine smears missed 77.8% of cases) and effectively detecting Pneumocystis jirovecii. The overall diagnostic sensitivity was 90.6% (95% CI: 87.5-93.1%) for mNGS and 73.4% (95% CI:69.2%-77.3%) for tNGS. Guided by tNGS results, clinicians escalated antimicrobial therapy in 22.6% of positive cases. The clinical improvement rate following this targeted escalation was 66.2%, comparable to the 66.7% improvement rate observed in patients receiving appropriate initial empirical therapy (P = 0.946). Both tNGS and mNGS offer substantial diagnostic value for LRTIs, with tNGS showing particular utility in identifying fastidious and low-titer pathogens. Sequencing-guided diagnostics frequently informed antimicrobial adjustments and were associated with favorable clinical progress; however, future prospective paired-testing studies are required to isolate the direct impact of sequencing on patient survival outcomes.
SN - 2235-2988
ER -